Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

We suffered a 4.6% drawdown on the Lithium Argentina position in 2024 but we have taken the opportunity to average down. Why ...

Billions in losses from natural disasters is triggering demand in sectors linked to wildfire recovery efforts. Read on for ...

Donaldson's strong Q1 performance, historical resilience, and solid financials positioning it for growth amid inflation and ...

Credo Technology and DeepSeek lead the way in AI and data centers. Read why CRDO stock’s 1.5x PEG ratio makes it an ...

Trump has said that he is looking for a TikTok deal in which US investors own at least a 50% stake in the platform. Read more ...

Slate Grocery has long carried a higher debt load than the typical US REIT. Click here to see why SRRTF is a Buy.

Nebius Group's market reaction is overly negative despite DeepSeek's efficiency. Learn why NBIS stock benefits from AI data ...

Copart's impressive financials include a 45% gross profit margin. Read why CPRT stock is a Sell despite strong market ...

A number of US banks booked lower-than-expected provisions for credit losses in the fourth quarter of 2024 against a backdrop ...

Thermo Fisher returned to growth in 4Q 2024 with 6.6% projected EPS growth. Learn why TMO stock’s leadership position and ...